Search
Results: 3
PIK3R1 W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma
D’Ambrosio, Erriquez, Arigoni, Capellero, Mittica, Ghisoni, Borella, Katsaros, Privitera, Ribotta, Maldi, Di Nardo, Berrino, Venesio, Ponzone, Vaira, Hall, Jimenez-Linan, Paterson, Calogero, Brenton, Valabrega, Di Renzo, Olivero
Feb 16, 2020
Identifying cancer drivers and actionable mutations is critical for precision oncology. In epithelial ovarian cancer (EOC) the majority of mutations lack biological or clinical validation. We fully characterized 43 lines of...
PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma.
Concetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Eleonora Ghisoni, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Marisa Ribotta, Elena Maldi, Giovanna Di Nardo, Enrico Berrino, Tiziana Venesio, Riccardo Ponzone, Marco Vaira, Douglas Hall, Mercedes Jimenez-Linan, Anna L Paterson, Raffaele A Calogero, James D Brenton, Giorgio Valabrega, Maria Flavia Di Renzo, Martina Olivero
Mar 10, 2020
Identifying cancer drivers and actionable mutations is critical for precision oncology. In epithelial ovarian cancer (EOC) the majority of mutations lack biological or clinical validation. We fully characterized 43 lines of...
PDX derived tumour cells PI3K PIK3R1 Patient-Derived xenografts ovarian cancer Animals Carcinoma Ovarian Epithelial Cell Line Tumor Class Ia Phosphatidylinositol 3-Kinase Cystadenocarcinoma Serous Female Heterografts Humans Mice Mice Inbred NOD Mice SCID Molecular Targeted Therapy Mutation Neoplasm Grading Ovarian Neoplasms Random Allocation
Thirteenth Annual ENBDC Workshop
The thirteenth annual workshop of the European Network for Breast Development and Cancer (ENBDC) Laboratories Annual Workshop took place on the 28-30 April 2022 in Weggis, Switzerland and focused on methods in mammary gland...